Ceruloplasmin:: measurement of serum ferroxidase activity

被引:0
作者
Yapur, Viviana Monica
Bustos, Maria Fernanda
Gonzalez, Analia Silvia
Negri, Gustavo Alberto
机构
来源
ACTA BIOQUIMICA CLINICA LATINOAMERICANA | 2007年 / 41卷 / 03期
关键词
ceruloplasmin; Wilson's disease; ferroxidase activity; moonlighting protein;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Ceruloplasmin (Cp) is the principal copper carrier in human plasma. It is an abundant protein that participates in the acute phase reaction to stress, but its physiological function is unknown. Althought Cp is synthesised predominantly in the liver, other cell types express the protein, including monocytes, astrocytes and Sertoli cells. The serum concentration of the copper protein ceruloplasmin has been an important diagnostic indicator of Wilson's disease. Measurement of the total amount of Cp protein may not reflect Cp enzyme activity in the serum. The immunologic assay may lead to overestimation of the total amount of functional Cp in the serum due to this method's capacity to determine both the functional holo Cp and non-functional apo Cp. Several methods for determining ferroxidase activity have been reported. In this study, a method is described for automated measurement of the activity. In this method, Fe2+ ions are used as the substrate. The range for serum Cp ferroxidase activity in healthy persons was 424-796 UI/L for women, and 397-733 UI/L for men. Significant correlations between serum ferroxidase activity and Cp concentration (r=0,7285; p < 0,0001) were found.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 14 条
  • [1] Structure to function relationships in ceruloplasmin: a 'moonlighting' protein
    Bielli, P
    Calabrese, L
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (09) : 1413 - 1427
  • [2] Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin
    Cauza, E
    MaierDobersberger, T
    Polli, C
    Kaserer, K
    Kramer, L
    Ferenci, P
    [J]. JOURNAL OF HEPATOLOGY, 1997, 27 (02) : 358 - 362
  • [3] Erel O, 1998, CLIN CHEM, V44, P2313
  • [4] FLEMING RE, 1991, AM J PHYSIOL, V260, P168
  • [5] The physiopathological significance of ceruloplasmin - A possible therapeutic approach
    Floris, G
    Medda, R
    Padiglia, A
    Musci, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (12) : 1735 - 1741
  • [6] STRUCTURE, OXIDANT ACTIVITY, AND CARDIOVASCULAR MECHANISMS OF HUMAN CERULOPLASMIN
    FOX, PL
    MUKHOPADHYAY, C
    EHRENWALD, E
    [J]. LIFE SCIENCES, 1995, 56 (21) : 1749 - 1758
  • [7] Ceruloplasmin metabolism and function
    Hellman, NE
    Gitlin, JD
    [J]. ANNUAL REVIEW OF NUTRITION, 2002, 22 : 439 - 458
  • [8] Identification of apo- and holo-forms of ceruloplasmin in patients with Wilson's disease using native polyacrylamide gel electrophoresis
    Hirano, K
    Ogihara, T
    Ogihara, H
    Hiroi, M
    Hasegawa, M
    Tamai, H
    [J]. CLINICAL BIOCHEMISTRY, 2005, 38 (01) : 9 - 12
  • [9] Molecular mechanisms for multitasking: recent crystal structures of moonlighting proteins
    Jeffery, CJ
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2004, 14 (06) : 663 - 668
  • [10] Wilson's disease
    Loudianos, G
    Gitlin, JD
    [J]. SEMINARS IN LIVER DISEASE, 2000, 20 (03) : 353 - 364